NYXH
|Nyxoah
NASDAQ
USD 7.71
-0.01|-0.13%
Current Price
USD 7.71
Change
USD -0.01 (-0.13%)
P/E Ratio
Dividend Yield
Market Cap
327.75M
Volume
117,780
Open
USD 7.47
Previous Close
USD 7.72
52-Week High
USD 11.87
52-Week Low
USD 5.55
About Nyxoah
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Sector:Healthcare
Industry:Medical Instruments & Supplies
CEO:Mr. Olivier Taelman
Employees:183
Headquarters:Mont-Saint-Guibert, Belgium
Website:www.nyxoah.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions